daiichisankyo.us

Website beoordeling daiichisankyo.us

Passion for innovation. Compassion for patients.- Daiichi Sankyo US

 Gegenereerd op Maart 12 2026 17:06 PM

Oude statistieken? UPDATE !

De score is 54/100

SEO Content

Title

Passion for innovation. Compassion for patients.- Daiichi Sankyo US

Lengte : 67

Perfect, uw title tag bevat tussen de 10 en 70 karakters.

Description

Learn about who we are, our approach to scientific innovation, our areas of therapeutic focus, our products, commitments and more.

Lengte : 130

Perfect, uw meta description bevat tussen de 70 en 160 karakters.

Keywords

home, homepage, landing

Goed, uw bevat meta keywords.

Og Meta Properties

Goed, uw page maakt gebruik van Og Properties.

Property Content
description Learn about who we are, our approach to scientific innovation, our areas of therapeutic focus, our products, commitments and more.
locale en_US
locale:alternate en_US
site_name DSI
title Passion for innovation. Compassion for patients.
type website
url https://daiichisankyo.us

Headings

H1 H2 H3 H4 H5 H6
1 34 0 0 0 0
  • [H1] Passion for Innovation. Compassion for Patients.®
  • [H2] Search Bar
  • [H2] Menu Display
  • [H2] Who We Are
  • [H2] Strategy
  • [H2] Purpose
  • [H2] Partners
  • [H2] Leadership
  • [H2] History
  • [H2] Patient Advocacy
  • [H2] Our Crafts
  • [H2] Compliance +
  • [H2] Transparency and Disclosure +
  • [H2] Corporate Grants and Giving +
  • [H2] Daiichi Sankyo Patient Support Programs
  • [H2] Supplier Diversity +
  • [H2] Transparency in Coverage
  • [H2] Rights & Protections Against Surprise Medical Bills
  • [H2] Our Science
  • [H2] Our Pipeline
  • [H2] Worldwide R&D Operations
  • [H2] Clinical Trial Information Disclosure
  • [H2] Expanded Access to Investigational Products
  • [H2] External Sponsored Research (ESR) Investigator Initiated Studies (IIS) and Collaborative Research (CR)
  • [H2] Breadcrumb
  • [H2] Creating New Standards of Care
  • [H2] Our Stories
  • [H2] Asset Publisher
  • [H2] Transforming Science into Medicines
  • [H2] Striving to Create Optimized Antibody Drug Conjugate (ADC) Technology
  • [H2] What's New
  • [H2] Asset Publisher
  • [H2] A Pipeline Pushing Us to Become a Global Leader in Oncology
  • [H2] Work with a Purpose
  • [H2] Menu Display

Afbeeldingen

We vonden 12 afbeeldingen in de pagina.

1 alt attributen ontbreken. Voeg alternatieve text toe zodat zoekmachines beter kunnen beoordelen wat het onderwerp van de afbeeldingen is.

Text/HTML Ratio

Ratio : 37%

Ideaal! De ratio van text tot HTML code is tussen de 25 en 70 procent.

Flash

Perfect, geen Flash content gevonden in uw website.

Iframe

Jammer, u heeft Iframes in uw website, dit betekent dat deze content niet kan worden geïndexeerd.

Herschreven URL

Perfect. Uw links zien er vriendelijk uit!

Underscores in de URLs

We hebben underscores gevonden in uw URLs. U zou het minteken moeten gebruiken ten behoeven van SEO.

In-page links

We vonden een totaal van 61 links inclusie 0 link(s) naar bestanden

Ankertekst Type samenstelling
Skip to content Intern doFollow
Healthcare Professionals Extern doFollow
Careers Intern doFollow
Contact Us Intern doFollow
Worldwide Extern doFollow
About Us Intern doFollow
Who We Are Intern doFollow
Strategy Intern doFollow
Purpose Intern doFollow
Partners Intern doFollow
Leadership Intern doFollow
History Intern doFollow
Patient Advocacy Intern doFollow
Our Crafts Intern doFollow
Compliance Intern doFollow
Standards Of Business Conduct Intern doFollow
Standards of Business Conduct & Ethics for Third Parties Intern doFollow
Daiichi Sankyo Group Global Anti-Bribery and Anti-Corruption Policy Intern doFollow
California Compliance Declaration Intern doFollow
California Supply Chains Act Intern doFollow
Daiichi Sankyo Group Employee Code of Conduct Intern doFollow
Transparency and Disclosure Intern doFollow
Post-marketing Commitments Intern doFollow
Working with Healthcare Professionals Intern doFollow
Vermont Pharmaceutical Marketer Price Disclosure Intern doFollow
Clinical Trial Information Disclosure Extern doFollow
Corporate Grants and Giving Intern doFollow
Independent Grants Intern doFollow
Sponsorships Intern doFollow
Charitable Contributions Intern doFollow
Daiichi Sankyo Requirements Intern doFollow
Corporate Support FAQs Intern doFollow
Daiichi Sankyo Patient Support Programs Intern doFollow
Supplier Diversity Intern doFollow
Supplier Registration Intern doFollow
Supplier Diversity FAQs Intern doFollow
Transparency in Coverage Intern doFollow
Rights & Protections Against Surprise Medical Bills Intern doFollow
Our Science Intern doFollow
Our Pipeline Extern doFollow
Worldwide R&D Operations Extern doFollow
Expanded Access to Investigational Products Extern doFollow
External Sponsored Research (ESR) Investigator Initiated Studies (IIS) and Collaborative Research (CR) Extern doFollow
Medicines Intern doFollow
Media Intern doFollow
Our Stories Intern doFollow
Home Intern doFollow
Learn More About Our Purpose Intern doFollow
View More Stories Intern doFollow
HER2 in Gynecologic Cancers—Why It Matters Intern doFollow
Showing Up for Patients: CARE Teams Inspire Hope in Their Communities Intern doFollow
Learn More About Our Science Intern doFollow
Explore the DXd ADC Technology Website Extern doFollow
View More News Intern doFollow
Patent Dispute Between Daiichi Sankyo and Seagen has Concluded Intern doFollow
ENHERTU Granted Priority Review in the US as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer Intern doFollow
Learn More About Our Medicines Intern doFollow
Terms & Conditions Intern doFollow
Privacy Notice Intern doFollow
Site Map Intern doFollow
Return Extern doFollow

SEO Keywords

Keywords Cloud

count patients enhertu treatment decreased cancer dose reactions metastatic adverse

Keywords Consistentie

Keyword Content Title Keywords Description Headings
patients 159
enhertu 159
decreased 89
adverse 60
count 55

Bruikbaarheid

Url

Domein : daiichisankyo.us

Lengte : 16

Favicon

Goed, uw website heeft een favicon.

Printbaarheid

Jammer. We vonden geen Print-Vriendelijke CSS.

Taal

Goed. Uw ingestelde taal is en.

Dublin Core

Deze pagina maakt geen gebruik van Dublin Core.

Document

Doctype

HTML 5

Encoding

Perfect. Uw ingestelde Charset is UTF-8.

W3C Validiteit

Fouten : 0

Waarschuwingen : 0

E-mail Privacy

Waarschuwing! Er is op zijn minst 1 e-mailadres gevonden als platte tekst. (voorkom spam!). Gebruik deze gratis antispam protector om e-mailadressen te verbergen voor spammers.

Niet ondersteunde HTML

Geweldig! We hebben geen niet meer ondersteunde HTMl tags gevonden in uw HTML.

Speed Tips

Geweldig, uw website heeft geen tabellen in een tabel.
Jammer, uw website maakt gebruik van inline styles.
Jammer, uw website heeft teveel CSS bestanden (meer dan 4).
Jammer, uw website heeft teveel JS bestanden (meer dan 6).
Jammer, uw website haalt geen voordeel uit gzip.

Mobile

Mobile Optimization

Apple Icon
Meta Viewport Tag
Flash content

Optimalisatie

XML Sitemap

Geweldig, uw website heeft een XML sitemap.

https://daiichisankyo.us/sitemap.xml

Robots.txt

https://daiichisankyo.us/robots.txt

Geweldig uw website heeft een robots.txt bestand.

Analytics

Perfect, uw website heeft een analytics tool.

   Google Analytics

PageSpeed Insights

Device
Categorieën

Free SEO Testing Tool

Website review is een gratis tool waarmee u eenvoudig uw website kunt analyseren